Jennifer A. Woyach, MD¹, Ian W. Flinn, MD PhD², Farrukh T. Awan, MD³, Herbert Eradat, MD⁴, Danielle Brander, MD⁵, Michael Tees, MD, MPH⁶, Sameer A. Parikh, MD⁷, Tycel J. Phillips, MD⁸, Razi Ghori^9*, Nishitha M. Reddy, MD^9*, Mohammed Z.H. Farooqui, DO⁹, John C. Byrd, MD¹⁰ and Deborah M. Stephens, DO¹¹

¹The Ohio State University, Columbus, OH
²Sarah Cannon Research Institute, Nashville, TN
³University of Texas Southwestern Medical Center, Dallas, TX
⁴David Geffen School of Medicine at UCLA, Los Angeles, CA
⁵Duke University, Duke PDC, Durham, NC
⁶Colorado Blood Cancer Institute, Denver, CO
⁷Mayo Clinic, Rochester, MN
⁸University of Michigan Rogel Cancer Center, Ann Arbor, MI
⁹Merck & Co., Inc., Rahway, NJ
¹⁰University of Cincinnati College of Medicine, Cincinnati, OH
¹¹University of Utah Huntsman Cancer Institute, Salt Lake City, UT

Anne Quinquenel, MD, PhD^1,2*, Rémi Letestu, MD^3*, Magali Le Garff-Tavernier^4*, Fabien Subtil^5*, Therese Aurran-Schleinitz^6*, Kamel Laribi, MD^7*, Florence Cymbalista, MD PhD^8*, Vincent Levy, MD, PhD^9*, Laurence Simon^10*, Damien Roos-Weil, MD, PhD^11*, Véronique Leblond, MD, PhD^12*, Marie-Sarah Dilhuydy, MD^13,14*, Caroline Dartigeas, MD^15*, Cecile Tomowiak, MD^16*, Romain Guieze, MD, PhD^17*, Olivier Tournilhac, MD, PhD^18*, Emmanuelle Ferrant, MD^19*, Sophie de Guibert, MD^20*, Pierre Feugier, MD, PhD^21*, Fatiha Merabet, MD^22*, Stephane Lepretre, MD^23*, Philippe Carassou^24*, Julie Gay, MD^25*, Bénédicte Hivert, MD^26*, Luc Mathieu Fornecker, MD, PhD^27*, Jehan Dupuis, MD^28*, Lysiane Molina, MD^29*, Bruno Villemagne, MD^30*, Guillaume Cartron, MD, PhD^31*, Bernard Drenou^32*, Béatrice Mahé, MD^33*, Omar Benbrahim, MD^34*, Xavier Cahu^35*, Christelle Portois^36*, Loic Ysebaert, MD, PhD^37*, Florence Nguyen Khac^38*, Valérie Rouille^39*, Alain Delmer⁴⁰ and Anne-Sophie Michallet, MD, PhD^41*

¹Hematology department, Robert Debré University Hospital, Reims, France
²UFR Médecine, Université Reims Champagne-Ardenne, Reims, France
³Hematology Laboratory, Avicenne Hospital, APHP, Bobigny, France
⁴Sorbonne Université-INSERM UMRS 1138, AP-HP, Hopital Pitie-Salpetriere, Service d’Hématologie Biologique, Paris, France
⁵Department of biostatistics, Hospices Civils de Lyon, LYON, France
⁶Institut Paoli Calmettes, Marseille, France
⁷Hématologie clinique, CH Le Mans, Le Mans, France
⁸Laboratory of Hematology, APHP, Hôpital Avicenne, Bobigny, France
⁹URC/CRC, Hopital Avicenne, AP-HP, Bobigny, France
¹⁰Centre Hospitalier Sud Francilien, Corbeil-Essonnes, FRA
¹¹Hematology Department,Sorbonne Universités, UPMC Univ Paris 06, GRC-11, Service d’Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris., Paris, France
¹²Département d’ Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France
¹³Department of hematology, Bordeaux, France
¹⁴CHU Hopitaux de Bordeaux, Pessac, France
¹⁵Department of Hematology and Cellular Therapy, CHRU de Tours, Hôpital Bretonneau, Tours, France
¹⁶Hematology, Poitiers University Hospital / INSERM CIC 1402, Poitiers, France
¹⁷Department of Hematology, CHU Clermont Ferrand, Clermont Ferrand, MA, France
¹⁸Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Hotel Dieu Hématologie, Clermont-Ferrand, France
¹⁹Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
²⁰Hématologie Clinique, CHU Rennes, Rennes, France
²¹Hematology Department, University Hospital of Nancy, Vandoeuvre, France
²²Service Hématologie et Oncologie, Hôpital André Mignot, Le Chesnay, France
²³Centre Henri Becquerel, Rouen, Rouen, FRA
²⁴CH Metz, Metz, FRA
²⁵Service d'Hématologie, Centre Hospitalier de la Côte Basque, Bayonne, France
²⁶GHICL, Lille, FRA
²⁷Department of Hematology, Strasbourg University Hospital, Strasbourg, France
²⁸Lymphoid Malignancies Department, Henri Mondor University Hospital, Créteil, France
²⁹Hématologie clinique, CHU de Grenoble, La Tronche, France
³⁰Clinical Hematology, Hospital of Vendée, La Roche-sur-Yon, France
³¹Hematology Department, Montpellier University Hospital, Montpellier, France
³²Department of Hematology, CH Mulhouse, Mulhouse, France
³³Hematology Department, Nantes University Hospital, Nantes, France
³⁴Hematology Department, CHR Orléans, Orleans, France
³⁵Hopital privé, Cesson sevigne, France
³⁶hematology, CHU Saint Etienne, Saint Etienne, France
³⁷Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
³⁸Sorbonne Université, Pitié-Salpêtrière Hospital, Paris Cedex 13, France
³⁹CHU Montpellier, Montpellier, France
⁴⁰Department of Hematology, CHU de Reims, Reims, Cedex, France
⁴¹Centre Hospitalier Lyon Sud, Hospices Civils, LYON, France

Arnon P. Kater, MD, PhD¹, Barbara Eichhorst, MD², Carolyn Owen, MD³, Ulrich Jaeger, MD⁴, Brenda Chyla, PhD⁵, Marcus Lefebure, PhD^6*, Rosemary Millen, PhD^6*, Yanwen Jiang, PhD^7*, Maria Thadani-Mulero, PhD^6* and John F. Seymour, MBBS, PhD, FRACP⁸

¹Amsterdam University Medical Centers, Amsterdam, Netherlands
²Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany
³University of Calgary, Calgary, AB, Canada
⁴Medical University of Vienna, Vienna, Austria
⁵AbbVie Inc., North Chicago, IL
⁶Roche Products Ltd., Welwyn Garden City, United Kingdom
⁷Genentech, Inc., South San Francisco, CA
⁸Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia

Anne-Sophie Michallet, MD, PhD^1*, Rémi Letestu, MD^2*, Magali Le Garff-Tavernier^3*, Carmen Aanaei^4*, Michel Ticchioni^5*, Marie-Sarah Dilhuydy, MD^6*, Stephane Morisset, BioStat^7*, Valérie Rouille^8*, Béatrice Mahé, MD^9*, Kamel Laribi, MD^10*, Bruno Villemagne, MD^11*, Emmanuelle Ferrant, MD^12*, Olivier Tournilhac, MD, PhD^13*, Alain Delmer¹⁴, Christelle Portois^15*, Lysiane Molina, MD^16*, Véronique Leblond, MD, PhD¹⁷, Cécile Tomowiak, MD^18*, Sophie de Guibert, MD^19*, Frederique Orsini^20*, Anne Banos, MD^21*, Philippe Carassou^22*, Guillaume Cartron, MD, PhD^23,24*, Luc Mathieu Fornecker, MD, PhD^25*, Loic Ysebaert, MD, PhD^26,27,28*, Caroline Dartigeas, MD^29,30*, Margot Truchan^31*, Jean-Pierre Vilque, MD^32*, Therese Aurran Schleinitz^33*, Cymbalista Florence^34*, Stéphane Leprêtre, MD^35,36*, Vincent Lévy^37*, Florence Nguyen Khac^38* and Pierre Feugier, MD, PhD^39*

¹Centre Hospitalier Lyon Sud, Hospices Civils, LYON, France
²Hematology Laboratory, Avicenne Hospital, APHP, Bobigny, France
³Hôpital Pité-Salpétrière, Paris, France
⁴CHU Saint Etienne, Saint- Etienne, France
⁵CHU NICE, NICE, France
⁶CHU Hopitaux de Bordeaux, Pessac, France
⁷Hematology, Centre Leon Berard, Lyon, France
⁸CHU Montpellier, Montpellier, France
⁹Hematology Department, Nantes University Hospital, Nantes, France
¹⁰Hématologie clinique, CH Le Mans, Le Mans, France
¹¹Clinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
¹²Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
¹³Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Hotel Dieu Hématologie, Clermont-Ferrand, France
¹⁴Department of Hematology, CHU de Reims, Reims, Cedex, France
¹⁵hematology, CHU Saint Etienne, Saint Etienne, France
¹⁶Hématologie clinique, CHU de Grenoble, La Tronche, France
¹⁷Department of Clinical Hematology, Sorbonne Université, APHP, Hôpital de la Pitié Salpêtriere, Paris, France
¹⁸Department of Hematology, CHU Poitiers, Poitiers, France
¹⁹Hématologie Clinique, CHU Rennes, Rennes, France
²⁰Service Hématologie, CH Annecy, ANNECY, France
²¹Hematology department, CH Côte Basque, Bayonne, France
²²CH Metz, Metz, FRA
²³Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
²⁴Hematology Department, Montpellier University Hospital, Montpellier, France
²⁵Department of Hematology, Strasbourg University Hospital, Strasbourg, France
²⁶IUCT-Oncopole, Toulouse, France
²⁷Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
²⁸Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France
²⁹Department of Hematology, Tours, FRA
³⁰Department of Hematology and Cellular Therapy, CHRU de Tours, Hôpital Bretonneau, Tours, France
³¹CHU angers, ANGERS, France
³²Institut d'Hématologie de Basse-Normandie, Centre François Baclesse, Caen, France
³³hematology, IPC, MARSEILLE, FRA
³⁴Avicenne Hospital, Bobigny Cedex, France
³⁵Inserm U1245 and Department of Hematology, Centre Henri Becquerel and Normandie Univ UNIROUEN, Rouen, France
³⁶CLCC H Becquerel, Rouen, France
³⁷Department of Clinical Research, APHP, Hôpital Avicenne, Bobigny, France
³⁸Sorbonne Université, Pitié-Salpêtrière Hospital, Paris Cedex 13, France
³⁹Hematology Department, University Hospital of Nancy, Vandoeuvre, France

Samantha M Teierle^1*, Ying Huang, MS, MA^2*, Adam S Kittai, MD², Seema A. Bhat, MD², Michael R. Grever, MD², Kerry A. Rogers, MD^2,3, Weiqiang Zhao, MD, PhD^4*, Daniel Jones, MD, PhD⁴, John C. Byrd, MD⁵, Matthew R Avenarius, PhD^4*, Nyla A. Heerema, PhD⁴, Jennifer A. Woyach, MD⁶ and Cecelia Miller, PhD^4*

¹Cytogenetic Department, Department of Pathology, The Ohio State University, Columbus, OH, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
⁴Department of Pathology, The Ohio State University, Columbus, OH
⁵University of Cincinnati College of Medicine, Cincinnati, OH
⁶Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH

Giulia Benintende, MD^1*, Idanna Innocenti, PhD^2*, Alberto Fresa, MD^2*, Francesco Autore, MD, PhD^3*, Annamaria Tomasso, MD^1*, Florenzia Vuono, Biologist^1*, Luca Stirparo, MD^1*, Antonio Mosca, MD^1*, Dimitar G Efremov, MD, PhD⁴, Andrea Bacigalupo, MD⁵ and Luca Laurenti, MD^1*

¹Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
²Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
³Sezione di Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
⁴Molecular Hematology, ICGEB - Molecular Hematology, Trieste, TS, Italy
⁵Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universita’ Cattolica del Sacro Cuore, Rome, Italy

Sabine Haggenburg^1,2*, Hannah Garcia Garrido, MD, PhD^3*, Iris Kant^1*, Fransien De Boer, MD, PhD⁴, Sabina Kersting, MD, PhD^5*, Doreen te Raa, MD, PhD^6*, Djamila E. Issa, MD, PhD^7*, Henny G. Otten, PhD^8*, Hein P.J. Visser, MD^9*, Arnon P. Kater, MD, PhD^1,10, Abraham Goorhuis, MD, PhD^11* and Koen de Heer, MD, PhD^1,12*

¹Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
²Amsterdam Institute of Infection and Immunity, Amsterdam UMC, Amsterdam, Netherlands
³Department of Infectious Diseases, Center for Tropical Medicine and Travel Medicine,Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
⁴Department of Hematology, Ikazia Hospital, Rotterdam, AN, NLD
⁵Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
⁶Department of Hematology, Hospital Gelderse Vallei, Ede, Netherlands
⁷Department of Hematology, Jeroen Bosch Hospital, Den Bosch, Netherlands
⁸Department of Medical Immunology, University Medical Center Utrecht, Utrecht, Netherlands
⁹Hematology, Medisch Centrum Alkmaar, Alkmaar, NLD
¹⁰Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, Netherlands
¹¹Department of Infectious Diseases, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
¹²Department of Internal Medicine, Flevohospital, Almere, Netherlands

Yotam Bronstein^1*, Shai Levi, MSc^1* and Yair Herishanu^1,2*

¹Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
²Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel

Lindsey Roeker, MD¹, Yi Han, PhD MBA^2*, Kellie J. Ryan, MPH^3*, Anna Teschemaker^3* and Anthony R. Mato, MD, MSCE¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Vinzent Strategies, Blue Bell, PA
³Global Medical Affairs, AstraZeneca Pharmaceuticals, Gaithersburg, MD

Farrukh T. Awan, MD¹, Gaurav A. Deshpande, PhD^2*, Trong Kim Le, MPH, MS^3*, Sean Garrison, PhD^2*, Simran K. Tiwana, MBA, PhD^2* and Masoom Priyadarshini, MPharm, MS^2*

¹University of Texas Southwestern Medical Center, Dallas, TX
²Bristol Myers Squibb, Princeton
³Bristol Myers Squibb, Princeton, NJ

Therese Aurran-Schleinitz^1*, Cécile Tomowiak, MD^2*, Damien Roos-Weil, MD, PhD^3*, Emmanuelle Ferrant, MD^4*, Béatrice Mahé, MD^5*, Lysiane Molina, MD^6*, Loic Ysebaert, MD, PhD^7*, Luc Mathieu Fornecker, MD, PhD^8*, Anne-Sophie Michallet, MD, PhD^9*, Vincent Levy, MD, PhD^10*, Romain Guieze, MD, PhD^11* and Alain Delmer¹²

¹Institut Paoli Calmettes, Marseille, France
²Department of Hematology, CHU Poitiers, Poitiers, France
³Department of Clinical Haematology, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
⁴Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
⁵Hematology Department, Nantes University Hospital, Nantes, France
⁶Hématologie clinique, CHU de Grenoble, La Tronche, France
⁷Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
⁸Department of Hematology, Strasbourg University Hospital, Strasbourg, France
⁹Centre Hospitalier Lyon Sud, Hospices Civils, LYON, France
¹⁰URC/CRC, Hopital Avicenne, AP-HP, Bobigny, France
¹¹Department of Hematology, CHU Clermont Ferrand, Clermont Ferrand, MA, France
¹²Department of Hematology, CHU de Reims, Reims, Cedex, France

Andrew C. Rawstron^1*, James Senior^1*, Nichola Webster^1*, Vicky Martin^1*, Ruth M. de Tute^1*, Talha Munir, MBBS, MRCP, FRCPath, PhD^2* and Peter Hillmen³

¹HMDS, Leeds Cancer Centre, Leeds, United Kingdom
²Consultant Haematologist, St James's Hospital, Leeds, United Kingdom
³Experimental Haematology, University of Leeds, Leeds, United Kingdom

Mehdi Parviz^1*, Rudi Agius^2*, Emelie Curovic Rotbain, MD^3*, Kathrine Aarup^4*, Noomi Vainer, MD^2* and Carsten Utoft Niemann, MD, PhD⁴

¹1Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, Copenhagen, AL, Denmark
²Rigshospitalet, Copenhagen, DNK
³Department of Hematology, Rigshospitalet, Copenhagen, Denmark
⁴Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Elizabeth Gaspard^1*, Pauline Frenoy^2*, Delphine Praud^3*, Thomas Coudon^3*, Leny Grassot^3*, Francesca Mancini^2*, Amandine Gelot^2*, Gianluca Severi^2*, Elodie Faure^2* and Caroline Besson⁴

¹Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Université Paris-Saclay, UPS UVSQ, Villejuif, France
²Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Facultés de Médecine, Université Paris-Saclay, UPS UVSQ, Villejuif, France
³Département Cancer Environnement, Centre Léon Bérard, Lyon, France
⁴CH de Versailles, Le Chesnay, France

Anisha V. Patel^1*, Abirami Vijenthira, MS, MD^1*, Aswin Sekar, MD, PhD^1*, Christopher J. Gibson, MD¹, Stephen P. Martindale^1*, Rayan Fardoun, BS^1*, Svitlana Tyekucheva, PhD^2*, Stacey M. Fernandes, BS^1*, Binyamin A. Knisbacher, PhD^3*, Cynthia K. Hahn, MD, PhD^1*, Gad Getz, PhD^3*, Catherine J. Wu, MD¹, Matthew S. Davids, MD¹ and Jennifer R. Brown¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Broad Institute of MIT and Harvard, Cambridge, MA

Marcelo Pitombeira de Lacerda, MD, PhD^1,2*, Fernanda de Morais Marques, MD^3,4, Verena Pfister^5*, Flavia de Carvalho Parra^6*, Vinicius Campos de Molla, MD⁷, Valeria Buccheri, PhD^8*, Rafael Dezen Gaiolla, PhD, MD^9*, Laura Maria Fogliatto¹⁰, Rodrigo Santucci, MD^11*, Marcelo Bellesso, MD^12*, Sérgio Costa Fortier, MD^13*, Talita M. B. Silveira, MD, PhD^14,15*, Glaciano Ribeiro, MD^16,17*, Nelson Hamerschlak, MD, PhD¹⁸, Mihoko Yamamoto, MD, PhD¹⁹, Matheus Vescovi Goncalves, MD, PhD^6,19,20*, Carlos S. Chiattone, MD, PhD^21,22 and Celso Arrais-Rodrigues, MD²³

¹Universidade da Região de Joinville (UNIVILLE), Joinville, Brazil
²Hospital Municipal São José (HMSJ), Joinville, Brazil
³Division of Hematology, Universidade Federal de São Paulo, Sao Paulo, Sp, Brazil
⁴Brazilian Registry of CLL, Associação Brasileira de Hematologia e Hemoterapia, Sao Paulo, Brazil
⁵Division of Hematology, Universidade Federal de São Paulo, Sao Paulo, Brazil
⁶Brazilian Registry of CLL, Associação Brasileira de Hematologia e Hemoterapia, São Paulo, Brazil
⁷Hematology Department, UNIFESP, Sao Paulo, Brazil
⁸Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), São Paulo, Brazil
⁹Hospital Das Clínicas UNESP, Distrito De Rubiao Junior, Botucatu, BRA
¹⁰Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
¹¹Instituto de Ensino e Pesquisa Sao Lucas - IEP Hemomed, Sao Paulo, SP, Brazil
¹²Instituto Hemomed de Oncologia e Hematologia, São PAULO, SAO PAULO, Brazil
¹³Hematology Division, Santa Casa de São Paulo Medical School, Sao Paulo, Brazil
¹⁴Hematology Discipline, Santa Casa de São Paulo Medical School, São Paulo, Brazil
¹⁵Department of Oncohematology, AC Camargo Cancer Center, Sao Paulo, Brazil
¹⁶Clínica Hematologica, Belo Horizonte - Minas Gerais, Brazil
¹⁷Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
¹⁸Hospital Israelita Albert Einstein, Sao Paolo, Brazil
¹⁹Division of Hematology, Universidade Federal de São Paulo, São Paulo, Brazil
²⁰Hematology, Fleury Medicina e Saúde, Sao Paulo, Brazil
²¹Oncology Nucleus, Samaritano Hospital - Higienopolis, Sao Paulo, Brazil
²²Department of Medicine, Santa Casa Medicine School, Sao Paulo, Brazil
²³Universidade Federal de São Paulo (UNIFESP), Sao Paulo, Brazil

Ali Abdelhay, md¹, Yousef Alabrach, MD^2*, Saryia Adra, MD^3*, Amir Mahmoud, MD^1*, Mohamad Mansour, MD^4* and Anas Hashem, MD^5*

¹Rochester General Hospital, Rochester, NY
²Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
³Al Qassimi Hospital, Sharjah, United Arab Emirates
⁴Tawam Hospital, Abu Dhabi, United Arab Emirates
⁵Rochester General Hospital, Rochester N.Y, NY

Andrea Visentin, MD, PhD^1*, Francesca Mauro, MD, PhD^2*, Lydia Scarfo, MD^3*, Massimo Gentile, MD^4*, Lucia Farina^5*, Gianluigi Reda, MD^6*, Isacco Ferrarini, MD PhD^7*, Giulia Proietti, MD^8*, Enrico Derenzini, MD, PhD^9*, Francesca Cibien, MD^10*, Candida Vitale^11*, Alessandro Sanna, MD^12*, Gioachino Catania, MD^13*, Monia Marchetti^14*, Roberta Murru^15*, Gian Matteo Rigolin^16*, Paolo Sportoletti, MD^17*, Luca Laurenti, MD^18*, Stefano Molica, MD¹⁹, Marta Coscia^20*, Paolo Ghia, MD, PhD²¹, Robin Foa, MD, PhD^22*, Antonio Cuneo^23* and Livio Trentin²⁴

¹Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
²Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy
³Università Vita-salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy
⁴Hematology Unit AO Cosenza, Cosenza, Italy
⁵Hematology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
⁶Hematology unit, Hematology Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
⁷Section of Hematology, Department of Medicine, University of Verona, Verona, Italy
⁸Hematology unit, Department of Translational and Precision Medicine, "Sapienza" University, Rome., Rome, Italy
⁹Oncohematology Division, IEO Istituto Europeo di Oncologia IRCCS, Milano, Italy
¹⁰Hematology unit, Ca’ Foncello Hospital, Treviso, Treviso, ITA
¹¹Department of Molecular Biotechnology and Health Sciences and Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
¹²Department of Hematology, AOU Careggi - University of Florence, Florence, Italy
¹³S.O.C. di Ematologia, Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
¹⁴Division of Hematology, Hospital Antonio e Biagio and Cesare Arrigo, Alessandria, Italy
¹⁵Hospital A. Businco, ARNAS “G. Brotzu”, Cagliari, CAGLIARI, Italy
¹⁶Hematology section, Department of Medical Sciences, Azienda Ospedaliera- Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy
¹⁷Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy
¹⁸Hematology institute, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
¹⁹Department Hematology-Oncology- Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro,Italy, Catanzaro, Italy
²⁰Division of Hematology, A.O.U. Cittàdella Salute e dellaScienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
²¹Universita' Vita-Salute San Raffaele C.F. 97187560152, Milano, MI, Italy
²²Hematology, Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy
²³St. Anna University Hospital, Ferrara, Italy
²⁴Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padova, Italy

Nilanjan Ghosh, MD¹, Jeff P. Sharman, MD², Jacqueline C. Barrientos, MD, MS³, Danielle Brander, MD⁴, Meghan Gutierrez, BA^5*, Linda Wu, PhD^6*, Zaina P. Qureshi, PhD, MS, MPH^6*, Sandhya Upasani, MS^7*, Maoko Naganuma, MSc^8* and Anthony R. Mato, MD, MSCE⁹

¹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Willamette Valley Cancer Institute & Research Center/US Oncology Research, Eugene, OR
³Mount Sinai Comprehensive Cancer Center, Miami Beach, FL
⁴Duke University Health System, Durham, NC
⁵Lymphoma Research Foundation, New York, NY
⁶Janssen, Horsham, PA
⁷Pharmacyclics LLC, an Abbvie Company, South San Francisco, CA
⁸Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA
⁹Memorial Sloan Kettering Cancer Center, New York, NY

John F. Seymour, MBBS, PhD, FRACP¹, John C. Byrd, MD², Talha Munir, MBBS, MRCP, FRCPath, PhD^3*, Paolo Ghia, MD, PhD⁴, Arnon P. Kater, MD, PhD⁵, Asher Chanan-Khan, MD⁶, Richard R. Furman, MD⁷, Susan M. O'Brien⁸, Jennifer R. Brown, MD, PhD⁹, Anthony R. Mato, MD, MSCE¹⁰, Stephan Stilgenbauer, MD¹¹, Thomas Fehn^12*, Paulo Andre P. de Miranda, MD¹³, Kara Higgins^12*, Ellie John^14*, Marianne de Borja^15*, Wojciech Jurczak¹⁶ and Jennifer A. Woyach, MD¹⁷

¹Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Victoria, Australia
²University of Cincinnati College of Medicine, Cincinnati, OH
³St. James’s University Hospital, Leeds, United Kingdom
⁴Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
⁵Amsterdam University Medical Centers, University of Amsterdam, on behalf of Hovon, Amsterdam, Netherlands
⁶Mayo Clinic Jacksonville, Jacksonville, FL
⁷Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY
⁸Chao Family Comprehensive Cancer Center, University of California-Irvine, Irvine, CA
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Memorial Sloan Kettering Cancer Center, New York, NY
¹¹University of Ulm, Ulm, Germany
¹²AstraZeneca, South San Francisco, CA
¹³AstraZeneca, Gaithersburg, MD
¹⁴AstraZeneca, Cambridge, United Kingdom
¹⁵AstraZeneca, Mississauga, Canada
¹⁶MSC National Research Institute of Oncology, Krakow, Poland
¹⁷Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY

Deborah M. Stephens, DO¹, Aaron Atkinson, PhD^1*, James Jack Abbott, MD^2*, Marianne Bowling, DNP^3*, Justin Williams, MPH^4*, Tony D. Pomicter, MS^4*, Lindsey A. Fitzgerald, MD⁵ and David Wada, MD^3*

¹Huntsman Cancer Institute, Salt Lake City, UT
²Dermatology, University of Utah, Salt Lake City, UT
³Dermatology, Huntsman Cancer Institute at University of Utah, Salt Lake City, UT
⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁵Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT